Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol

BACKGROUND: Speech impairments are an early feature of Alzheimer’s disease (AD) and consequently, analysing speech performance is a promising new digital biomarker for AD screening. Future clinical AD trials on disease modifying drugs will require a shift to very early identification of individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: König, Alexandra, Linz, N., Baykara, E., Tröger, J., Ritchie, C., Saunders, S., Teipel, S., Köhler, S., Sánchez-Benavides, G., Grau-Rivera, O., Gispert, J. D., Palmqvist, S., Tideman, P., Hansson, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851094/
https://www.ncbi.nlm.nih.gov/pubmed/36946458
http://dx.doi.org/10.14283/jpad.2023.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9851094/
https://www.ncbi.nlm.nih.gov/pubmed/36946458
http://dx.doi.org/10.14283/jpad.2023.11

Ejemplares similares